MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
Previous studies reported that miR-330-3p was involved in the progression of several cancers, but the potential roles of miR-330-3p in ovarian cancer (OC) were unclear. In the current study, we aimed to explore the expression pattern and functions of miR-330-3p in OC. The expression level of miR-330...
Main Authors: | Li Cai, Lu Ye, Xiaoqing Hu, Wenfeng He, Debao Zhuang, Qi Guo, Kuanyong Shu, Youkun Jie |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Bioengineered |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21655979.2021.1871817 |
Similar Items
-
MicroRNA-4287 alleviates inflammatory response via targeting RIPK1 in osteoarthritis
by: Mingyang Xia, et al.
Published: (2022-07-01) -
RIPK4 Promotes Cell Invasion and the Epithelial–Mesenchymal Transition in Ovarian Cancer
by: Li Hua, et al.
Published: (2023-12-01) -
The Role of RIPK1 and RIPK3 in Cardiovascular Disease
by: Elise DeRoo, et al.
Published: (2020-10-01) -
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
by: Yuqing Shen, et al.
Published: (2022-04-01) -
RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
by: Xuedong Wang, et al.
Published: (2023-11-01)